Tear Film Innovations completes $9MM Series A financing co-led by Visionary Ventures and Tigris Ventures
Tear Film Innovations completes $9MM Series A financing co-led by Visionary Ventures and Tigris Ventures
PWC Healthcare MoneyTree Report Q2 2017 Names Visionary Ventures the Number 3 Most Active Venture Fund in Healthcare
PWC Healthcare MoneyTree Report Q2 2017 Names Visionary Ventures the Number 3 Most Active Venture Fund in Healthcare.
IanTECH Completes Financing co-led by Visionary Ventures and GHIF
Funding for IanTECH’s Next Generation Ophthalmic Device Supports Goal to Alleviate Cataract-induced Blindness in 25 Million.
TearClear Completes $4.5MM Series A Financing co-led by Visionary Ventures
TearClear closes series A financing and introduces leadership team of accomplished ophthalmology veterans with the proceeds going to advance the development of the Company’s delivery system for preservative-free ophthalmic drugs.
Orange County Has $12.5 Billion Annual Impact: Global Center of Ophthalmology
The Economic Impact of the Ophthalmic Goods Manufacturing Industry on the Southern California Economy.